Everything you’ve always wanted to know about the use of methotrexate (MTX) in sarcoidosis.
Help is at hand. There’s an app for that!
This concise and useful app gives 10 recommendations on how to use MTX in sarcoidosis
clinical practice. That’s a first!
Based on the expert opinions from the world’s leading sarcoidologists combined with evidence-based recommendations from the literature, this app provides the physician with a tremendous amount of distilled information in the use of MTX.
You will find recommendations from Current Opinion in Pulmonary Medicine and links to other scientific publications, along with clinical cases demonstrating the treatment and effect of MTX.
You can also ask questions and make suggestions by your own!
Methotrexate is the second-line drug of choice in cases of steroid resistance or adverse steroid reactions; it is useful as a steroid-sparing agent as well. The app was developed on behalf the ild care foundation in cooperation with WASOG. The information will be continuously updated. You can find the free app in the App Store and Google Play.
The Drug-Induced Respiratory Disease Website
Pneumotox.com is updated with relevant literature daily. You may complement Ptox by your own search on PubMed and the FDA AE reporting system. Do not hesitate to notify us anything we might have missed (click on ‘Contact’ on frontpage. Current figures are 1100 drugs, chemicals, abused & illicit substances or procedures. Over 200 patterns of involvement. 23150 references in the Pneumotox database (of which about 7000 cited) as of May 18, 2015.